⚖️DEA Temporarily Schedules New Synthetic Opioids - Compliance Needed
The Drug Enforcement Administration issues this temporary order to schedule two benzimidazole-opioids in schedule I of the Controlled Substances Act. DEA bases this action on a finding that placing these substances in schedule I is necessary to avoid imminent hazard to public safety. This order imposes the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis, or possess) or propose to handle these substances.
Learn More📦New Duties on Low-Value Imports from China to Combat Opioid Crisis
Executive Order 14256 addresses the illicit shipment of synthetic opioids from the People’s Republic of China and Hong Kong. The order revokes duty-free treatment for low-value imports, mandating new duty payments on eligible products entered for consumption after May 2, 2025. It aims to enhance U.S. trade compliance and revenue collection while monitoring the opioid crisis' impact.
Learn More📉Executive Order Raises Tariffs on Chinese Imports for Opioid Crisis
Executive Order 14228 addresses the ongoing threat posed by synthetic opioids, specifically from China. The order amends previous executive actions and increases tariffs on related products, citing insufficient action by the PRC to mitigate this issue. The measure emphasizes national security concerns linked to drug trafficking and economic stability.
Learn More⚖️Executive Order Imposes Tariffs on Chinese Goods to Combat Opioid Crisis
Executive Order 14195 addresses the urgent synthetic opioid crisis exacerbated by the People's Republic of China's role in drug trafficking. It imposes a 10% duty on PRC products effective February 4, 2025, as a response to the failure of Chinese authorities to curb the flow of dangerous substances. The order emphasizes a commitment to protecting American citizens and addressing the growing public health emergency.
Learn More